These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22888592)

  • 1. Potency testing of veterinary rabies vaccines: replacement of challenge by in vitro testing: considerations for development of alternative assays.
    Lewis CE; Fry AM; Hermann JR; Siev D; Dusek DM; Gatewood DM
    Dev Biol (Basel); 2012; 134():29-33. PubMed ID: 22888592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a non-invasive, inhalational challenge method for rabies vaccine potency assay.
    Lewis CE; Reising MM; Fry AM; Conrad SK; Siev D; Gatewood DM; Hermann JR
    J Virol Methods; 2013 Jun; 190(1-2):49-52. PubMed ID: 23557669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
    Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
    Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use.
    Krämer B; Kamphuis E; Hanschmann KM; Milne C; Daas A; Duchow K
    Biologicals; 2013 Nov; 41(6):400-6. PubMed ID: 24144483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The validation of potency tests: hurdles identified by EMA/CVMP/IWP.
    Woodland R
    Dev Biol (Basel); 2012; 134():69-73. PubMed ID: 22888597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potency testing of veterinary vaccines for animals: the way from in vivo to in vitro. Workshop summary.
    Dev Biol (Basel); 2012; 134():149-52. PubMed ID: 22888608
    [No Abstract]   [Full Text] [Related]  

  • 7. Collaborative study for validation of a serological potency assay for rabies vaccine (inactivated) for veterinary use.
    Krämer B; Bruckner L; Daas A; Milne C
    Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):37-55. PubMed ID: 21144488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards in vitro potency testing of inactivated erysipelas vaccines.
    Balks E; Wolf C; Loessner H; Werner E
    Dev Biol (Basel); 2012; 134():37-44. PubMed ID: 22888593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rabies vaccine standards: comparison of the 5th and 6th WHO international reference standards to the USDA veterinary reference standard.
    Hermann J; Fry A; Reising M; Patterson P; Siev D; Gatewood D
    Vaccine; 2012 Nov; 30(48):6892-6. PubMed ID: 22981761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EDQM biological reference preparation for rabies vaccine (inactivated) for veterinary use.
    Daas A; Bruckner L; Milne C
    Pharmeur Bio Sci Notes; 2015; 2015():57-72. PubMed ID: 26830159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro vaccine potency testing: a proposal for reducing animal use for requalification testing.
    Brown K; Stokes W
    Dev Biol (Basel); 2012; 134():75-81. PubMed ID: 22888598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the single radial immunodiffusion test as a replacement for the NIH mouse potency test for rabies vaccine.
    Fitzgerald EA; Needy CF
    Dev Biol Stand; 1986; 64():73-9. PubMed ID: 3098606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antigen measurement and potency tests: challenges encountered during method development...and lessons learned.
    Kubiak V
    Dev Biol (Basel); 2012; 134():83-91. PubMed ID: 22888599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress and future directions for reduction, refinement, and replacement of animal use in veterinary vaccine potency and safety testing: a report from the 2010 NICEATM-ICCVAM International Vaccine Workshop.
    Stokes WS; Kulpa-Eddy J; Brown K; Srinivas G; McFarland R
    Dev Biol (Basel); 2012; 134():9-21. PubMed ID: 22888590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical endpoints during rabies vaccine control tests].
    Hartinger J; Folz T; Cussler K
    ALTEX; 2001; 18(1):37-40. PubMed ID: 11248849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: state of the science and planning the way forward.
    Stokes W; McFarland R; Kulpa-Eddy J; Gatewood D; Levis R; Halder M; Pulle G; Kojima H; Casey W; Gaydamaka A; Miller T; Brown K; Lewis C; Chapsal JM; Bruckner L; Gairola S; Kamphuis E; Rupprecht CE; Wunderli P; McElhinney L; De Mattia F; Gamoh K; Hill R; Reed D; Doelling V; Johnson N; Allen D; Rinckel L; Jones B
    Biologicals; 2012 Sep; 40(5):369-81. PubMed ID: 22884673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an animal rabies vaccine by use of two types of potency tests.
    Baer GM
    Am J Vet Res; 1997 Aug; 58(8):837-40. PubMed ID: 9256966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro potency tests: challenges encountered during method development.
    Yomayuza CL; Thiel HJ; König M
    Dev Biol (Basel); 2012; 134():93-100. PubMed ID: 22888600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potency test which simulates natural exposure for measuring post-exposure activity of rabies vaccines. A proposal for preparing a relevant international reference preparation.
    Bijlenga G
    Dev Biol Stand; 1978; 40():203-8. PubMed ID: 567153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A step forward in the quality control testing of inactivated rabies vaccines - extensive evaluation of European vaccines by using alternative methods to the in vivo potency tests.
    Servat A; Kempff S; Brogat V; Litaize E; Schereffer JL; Cliquet F
    Altern Lab Anim; 2015 Mar; 43(1):19-27. PubMed ID: 25802995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.